معرفی
Surafel Tegegne is a Research Fellow and bioinformatician at Monash University, affiliated with the Cellular and Molecular Metabolism Laboratory (CMML) under the Drug Discovery Biology theme. His work focuses on integrating multi-omics data and applying bioinformatics tools to identify novel drug targets in metabolic diseases such as obesity, diabetes, and NASH. His research contributes to UN Sustainable Development Goals related to health and well-being.
Research Interests: His primary research areas include bioinformatics, multi-omics data integration, cellular and molecular metabolism, nutrition, and metabolic disease modeling. He utilizes systems biology approaches to understand complex metabolic pathways and their dysregulation in disease states. His expertise spans computational analysis, metabolic network modeling, and molecular phenotyping.
Publication Trends: Over the past decade, Dr. Tegegne's publications have centered on metabolic disease mechanisms, particularly using Caenorhabditis elegans as a model system. His recent work in 2023–2024 focuses on therapeutic interventions for NASH and lipid metabolism, including ceramide biosynthesis and ER stress pathways. Earlier work examined nutritional deficiencies and herbal medicine applications.
- Scientific Awards:
No specific awards or fellowships are mentioned in the provided text.
Advising and Grants: There is no information available regarding student supervision, grant funding, or leadership of research projects. However, he has collaborated with prominent researchers at Monash University on high-impact studies published in journals like Science Advances.
Laboratory and Team: Dr. Tegegne is a key member of the Cellular and Molecular Metabolism Laboratory (CMML) at Monash University, operating under the Drug Discovery Biology program. This team conducts interdisciplinary research combining bioinformatics, molecular biology, and metabolic phenotyping to advance therapeutic discovery.
